Japan PBSS Hosts 1st Webinar on 'AI x Drug Discovery'
Japan PBSS held its first webinar featuring Associate Professor James Zou from Stanford University to discuss the frontiers of AI in drug discovery. The event introduced frameworks like 'Virtual Lab' and 'Virtual Biotech' to an audience of over 70 participants.
📋 Article Processing Timeline
- 📰 Published: April 15, 2026 at 19:30
- 🔍 Collected: April 15, 2026 at 11:01
- 🤖 AI Analyzed: April 15, 2026 at 17:26 (6h 24m after Collected)
The Japan Pharmaceutical & BioScience Society (Japan PBSS) hosted its inaugural webinar, inviting Associate Professor James Zou from Stanford University to speak on the intersection of AI and drug discovery research. The lecture introduced two key initiatives from Prof. Zou's research group: 'Virtual Lab,' where LLM-powered AI agents collaborate with human researchers on nanobody design, and 'Virtual Biotech,' which simulates corporate roles with AI agents to support clinical data analysis and risk evaluation. The session emphasized AI's role as a partner that expands the speed and scope of human research rather than replacing it. Japan PBSS plans to continue providing opportunities for knowledge sharing in the bioscience field.
FAQ
What were the main AI frameworks introduced in the webinar?
The lecture highlighted 'Virtual Lab' and 'Virtual Biotech,' developed by Associate Professor James Zou's research group.